Valorization of Soybean (Glycine max (L.) Merr.) Processing By-Products: Pharmacological Properties and Clinical Significance: A Comprehensive Review
Journal for Research in Applied Sciences and Biotechnology · 30.04.2026 · 5 (2) · 70-81
DOI: 10.55544/jrasb.5.2.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for Research in Applied Sciences and Biotechnology, online erschienen am 30.04.2026. Verfasst von Vandna und 5 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The number of soy-based goods accessible has expanded in recent years due to a shift towards less environmentally conscious agriculture, increasing understanding of the health advantages of ingesting soy-based meals, and an understanding of milk-related concerns. The Pacific area is home to China, South America, and the United States, the world's top producers. Alongside this huge manufacturing, a number of related by-products, including a material called okara, accumulate. The Okara variety is a kind of paste that is high in vitamins, small amounts of fat (10%), protein (25%), and fiber (50%). When used properly, it would have positive economic effects and lessen the possibility of environmental pollution. However, the product's high level of moisture (70–80%) causes it to deteriorate quickly, making it challenging to handle and costly to dry using traditional methods. Therefore, the purpose of this work is to design a generic strategy for okara harvesting and valorization by carefully examining the literature already available on the topic. Vegetable soybeans are regarded as an alimentary crop or a nutraceutical since they are high in phytochemicals that are good for humans. People all over the world are interested in soybeans as a "functional food" that lowers the risk of a number of dangerous conditions, including osteoporosis, atherosclerosis, and several cancers, including breast, uterine, and prostate cancer.
Zitieren
APA
Vandna, Trivedi, S., Dubey, A., Sahu, V. K., Dash, S. L., & Mishra, A. (2026). Valorization of Soybean (Glycine max (L.) Merr.) Processing By-Products: Pharmacological Properties and Clinical Significance: A Comprehensive Review. Journal for Research in Applied Sciences and Biotechnology, 5(2), 70-81. https://doi.org/10.55544/jrasb.5.2.9
Vancouver
Vandna, Trivedi S, Dubey A, Sahu VK, Dash SL, Mishra A. Valorization of Soybean (Glycine max (L.) Merr.) Processing By-Products: Pharmacological Properties and Clinical Significance: A Comprehensive Review. Journal for Research in Applied Sciences and Biotechnology. 2026;5(2):70-81. doi:10.55544/jrasb.5.2.9
BibTeX
@article{Vandna2026,
author = {Vandna and Trivedi, Swati and Dubey, Anubhav and Sahu, Vikram Kumar and Dash, Sribatsa Lanchhana and Mishra, Amit},
title = {Valorization of Soybean (Glycine max (L.) Merr.) Processing By-Products: Pharmacological Properties and Clinical Significance: A Comprehensive Review},
journal = {Journal for Research in Applied Sciences and Biotechnology},
year = {2026},
volume = {5},
number = {2},
pages = {70--81},
doi = {10.55544/jrasb.5.2.9}
}
EUVIMED